Cargando…
The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients
BACKGROUND: In colorectal cancer, hPG80 (progastrin) is released from tumor cells, promotes cancer stem cells (CSC) self-renewal and is detected in the blood of patients. Because the gene GAST that encodes hPG80 is a target gene of oncogenic pathways that are activated in many tumor types, we hypoth...
Autores principales: | You, Benoit, Mercier, Frédéric, Assenat, Eric, Langlois-Jacques, Carole, Glehen, Olivier, Soulé, Julien, Payen, Léa, Kepenekian, Vahan, Dupuy, Marie, Belouin, Fanny, Morency, Eric, Saywell, Véronique, Flacelière, Maud, Elies, Philippe, Liaud, Pierre, Mazard, Thibault, Maucort-Boulch, Delphine, Tan, Winston, Vire, Bérengère, Villeneuve, Laurent, Ychou, Marc, Kohli, Manish, Joubert, Dominique, Prieur, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938867/ https://www.ncbi.nlm.nih.gov/pubmed/31877416 http://dx.doi.org/10.1016/j.ebiom.2019.11.035 |
Ejemplares similares
-
Prognostic Value of Plasma hPG(80) (Circulating Progastrin) in Metastatic Renal Cell Carcinoma
por: Kohli, Manish, et al.
Publicado: (2021) -
Plasma hPG(80) (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort
por: Prieur, Alexandre, et al.
Publicado: (2023) -
hPG(80) (circulating progastrin) as a blood biomarker for high-grade glial tumors: A pilot study
por: Casile, Melanie, et al.
Publicado: (2023) -
Plasma hPG(80) (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Dupuy, Marie, et al.
Publicado: (2022) -
hPG(80) (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors
por: Chauhan, Aman, et al.
Publicado: (2022)